HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn's disease and ankylosing spondylitis.

AbstractBACKGROUND:
To clarify the impact of T cell responses towards enteric antigens for chronic intestinal inflammation, we determined T helper 1 reactivity towards conserved Escherichia coli proteins in patients with Crohn's disease (CD) and healthy individuals and patients with ankylosing spondylitis (AS), who also often show microscopic inflammatory lesions within the gut or even develop overt inflammatory bowel disease.
METHODS:
We determined the frequency of IFNγ+CD40L+ cells/CD4+ T cells after stimulation of whole blood with pools of E. coli proteins.
RESULTS:
The E. coli-specific Th1 response was significantly reduced in CD patients and to a lower extent also in AS patients.
CONCLUSIONS:
E. coli is a target for polyclonal Th1 responses in healthy individuals. The impairment of these responses in CD and AS patients might be due to recruitment of enterobacteria-specific Th1 cells to the gut or might reflect inadequate priming of adaptive immune response.
AuthorsAsgar Ergin, Uta Syrbe, Rebecca Scheer, Andreas Thiel, Thomas Adam, Konrad Büssow, Rainer Duchmann, Martin Zeitz, Joachim Sieper
JournalJournal of clinical immunology (J Clin Immunol) Vol. 31 Issue 6 Pg. 998-1009 (Dec 2011) ISSN: 1573-2592 [Electronic] Netherlands
PMID21901394 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Escherichia coli Proteins
  • CD40 Ligand
  • Interferon-gamma
Topics
  • Adaptive Immunity
  • Adolescent
  • Adult
  • CD4-Positive T-Lymphocytes (immunology, metabolism, pathology)
  • CD40 Ligand (metabolism)
  • Cell Movement
  • Child
  • Child, Preschool
  • Crohn Disease (immunology, physiopathology)
  • Escherichia coli Proteins (immunology)
  • Female
  • Humans
  • Immunosuppression Therapy
  • Infant
  • Inflammation
  • Interferon-gamma (metabolism)
  • Intestines (pathology)
  • Male
  • Spondylitis, Ankylosing (immunology, physiopathology)
  • Th1 Cells (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: